Gene therapy with modified tumor cells enables T-cell activation by stimulating pathways required for signal transduction

Cytokines and Molecular Therapy

Volumn 2, Issue 3, 1996, Pages 171-176

  Salvador, Silvia ^a   Zier, Karen ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Gene therapy; IL 2; Signal transduction; T cells

Indexed keywords

INTERLEUKIN 2; PHOSPHOTRANSFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; GENE THERAPY; IMMUNOBLOTTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TUMOR CELL; TUMOR IMMUNITY;

ANIMALS; FIBROSARCOMA; GENE THERAPY; GENETIC ENGINEERING; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; PHOSPHOTYROSINE; PROTEIN-TYROSINE KINASES; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 0029851385     PISSN: 13556568     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Pardoll DM, Cancer vaccines. Immunol Today (1993) 14:310-16.
2. Zier KS, Gansbacher B, Salvadori S, Preventing molecular abnormalities of T cells in cancer: the promise of cytokine gene therapy. Immunol Today (1996) 17: 39-45.
3. Allison JP, Hurwitz AA, Leach DR, Manipulation of costimulatory signals to enhance antitumor T-cell responses. Citrr Opin Immunol (1995) 7: 682-6.
4. Pardoll D, A new look for the 1990s. Nature (1994) 369: 357-8.
5. Boon T, Cerottini J-C, Van den Eynde B et al, Tumor antigens recognized by T lymphocytes. Annn Rev Immunol (1994) 12: 337-65.
6. Salvadori S, Gansbacher B, Pizzimenti A, Zier K, Abnormal signal transduction by T cells of mice with parental tumors is not seen in mice bearing IL2-secreting tumors. J Immunol (1994) 153: 5176-82.
7. Salvadori S, Gansbacher B, Zier KS, Functional differences are associated with abnormal signal transduction in T cells of mice inoculated with parental but not IL-2 secreting tumor cells. Cancer Gene Ther (1994) 3: 165-70.
8. Gansbacher B, Zier K, Daniels B et al, Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity, jf Exp Med (1990) 172: 1217-24.
9. Arpaia E, Shahar M, Dadi H et al, Defective T cell receptor signaling and CD8+ thymic selection in humans lacking ZAP-70 kinase. Cell (1994) 76: 947-58.
10. Elder ME, Lin D, Clever J et al. Human severe combined immunodeficiency due to a defect in ZAP70, a T cell tyrosine kinase. Science (1994) 264: 1596-9.
11. Sloan-Lancaster J, Shaw AS, Rothbard JB, Allen PM, Partial T cell signaling: altered phospho-zeta and lack of ZAP-70 recruitment in APL-induced T cell anergy. Cell (1994) 79: 913-22.
12. Salvador! S, Zier KS, The molecular basis of T cell dysfunction in cancer is influenced by the paracrine secretion of tumor-derived IL-2. J Immunol (1996) 156: 2927-32.
13. Salvadori S, Gansbacher B, Wernick I et al, B7-1 transfected tumor cells induce a response in syngeneic hosts in vivo, but fail to stimulate naive allogeneic cells in vitro. Human Gene Ther (1995) 6: 1299-306.
14. Mizoguchi H, O'Shea JJ, Longo DL et al, Alteration in signal transduction molecules in T lymphocytes from tumor bearing mice. Science (1992) 258: 1795-8.
15. Farace F, Angevin E, Vanderplaricke J et al, The decreased expression of CI3 £chains in cancer patients is not reversed bvy IL-2 administration. Int J Cancer (1994) 59: 752-5L
16. Finke JH, Zea AH, Stanley J et al, Loss of T-cell receptor £chain and p561ck in T-cells infiltrating human renal cell carcinoma. Cancer Res (1993) 53: 5613-16.
17. Nakagomi H, Peterson M, Magnusson I et al, Decreased expression of the signal-transducing £chains in tumorinfiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer Res (1993) 53: 5610-12.
18. George AJT, Stevenson FK, Prospect for the treatment of B cell tumors using idiotypic vaccination. Int Rev Immimol (1989) 4: 271-310.
19. Ghosh P, Sica A, Young HA, Alterations in NPKB/Rel family proteins in splenic T-cells from tumor-bearing mice and reversal following therapy. Cancer Res (1994) 54: 2969-72.
20. Irving BA, Weiss A, The cytoplasmic domain of the T cell receptor zeta chain is sufficient to couple to receptor-associated signal transduction pathways. Cell (1991) 64:891-901.
21. Minami Y, Kono T, Miyazaki T, Taniguchi T, The IL-2 receptor complex: its structure, function and target genes. Anmi Rev Immimol (1993) 11: 245-68.
22. Johnston JA, Kawamura M, Kirken RA et al, Phosphorylation and activation of the Jak-3 kinase in response to interleukin-2. Nature (1994) 370: 151-3.